Antibiotics_WalworthPilch Flashcards
MBC (minimal bacteriacidal concentration) - YES within therapeutic range of drug
Bacteriacidal (cell-wall active agent) - Rifampin, quinolones
Toxic Dose/Effective Dose
Therapeutic Index
Therapeutic Index >1 __
Therapeutic Index
Susceptibility
Resistance
Timeline of Antibiotic Drug Therapy
- Prophylactic (no infection) -> Pre-emptive
- Empiric (after infection, cultures of blood/infection site + lab techniques [gram stain/strep test]) - single, broad spectrum agent [causative microorganism NOT yet defined]
- Definitive - Specific and narrow-spectrum agent
[causative microorganism YES defined]
Type of empiric therapy used to:
INCREASE antimicrobial activity for specific infection
DECREASE resistance + host toxicity
Combination Therapy
Combination Therapy Criteria
Usually use two agents that differ in mechanism (SIGNIFICANTLY lowered frequency of resistance)
What disease do you especially use combination therapy?
Tuberculosis
COMBINATION THERAPY: Relationship between bacteriostatic and bacteriacidal drugs
Bacteriostatic (Tetracyclins) ANTAGONIZE bacteriocidal (beta-lactams, rifampin, quinolones, aminoglycoside)
COMBINATION THERAPY: Relationship between combined usage of bacteriacidal drugs
Synergistic (one drug potentiates the inhibitory effect of the other)
Additive (one drug independent of action of other drug)
MIC (minimal inhibitory concentration) - YES, within therapeutic range of drug
MBC (minimal bacteriacidal concentration) - NO within therapeutic range of drug
Bacteriostatic agent (protein synthesis inhibitors)
MDR
Multi-drug resistant bacteria
4 Genetic Mechanisms of Developing Antibiotic Resistance
- Transformation - uptake of DNA from environment
- Transduction - uptake of DNA from bacteriophage (viral vector)
- Conjugation - transfer of plasmid from one bacterial cell to another by direct contact and pilus formation
- Transposition - for the antibiotic resistance gene to be phenotypically expressed by the bacteria, the gene has to be transferred from the plasmid to the bacterial chromosome (via insertion sequences)
beta-lactam antibiotics
penicillin (subclass: amoxicillin), methicillin, oxacillin, nafcillin, ampicillin + cephalosporins
AMINOGLYCOSIDE Antibiotics
Gentamicin Neomycin Amikacin Tobramycin Streptomycin Kanamycin
beta-lactamase inhibitor
- beta-lactamase: bacteria evolved and acquired mutation in beta-lactamase that cleaves/renders inactive beta-lactams (penicillin/cephalosporin)
- CLAVULANIC ACID
Combination Therapy: Amoxicillin (beta-lactam) + Clavulanic acid (beta-lactamase inhibitor)
Augmentin
Most common anti-fungal agent and its action
5-flucytosine
Action: Inhibits formation of dTMP -> Decreases fungal DNA synthesis
Caveat: Requires 3 metabolic enzymes to work - cytosine deaminase, UMP pyrophosphorylase, ribonucleotide reductase
Resistance to 5-flucytosine (anti-fungal agent) is most likely due to __
Downregulation of UMP PYROPHOSPHORYLASE - Enz required for the conversion of 5-flucytosine to a more active compound and its effect of decreasing fungal dTMP (DNA) synthesis
Combination Therapy: Sulfonamide + Trimethoprim (Synergistic Relationship)
Block 2 steps within the same pathway
Bactrim
Only time that bactrim will not work:
Mechanism of bacteria developing bactrim resistance
Overproduction of p-aminobenzoic acid (PABA): Increased flux of reacting metabolite to overcome competitive, antagonistic drug sulfonamide (part of bactrim)
LARGEST GROUP of ANTIBIOTICS = cell wall inhibitors
[ALL BACTERIACIDAL by weakening cell wall -> bacteria rupture by osmotic lysis]
beta-lactams (penicillin/amoxicillin + cephalosporins)
NOT beta-lactams (vancomycin)
carbapenems
monobactams
Mechanism in which bacteria acquired VRE (mostly enterocci and moderately in staphylococci)
Bacteria acquired DNA to produce a mutational proteoglycan matrix of the cell wall: 3 genes (VanHAX operon) that encoded for D-Ala-D-lactate (instead of D-Ala-D-Ala, target of vancomycin) -> Vancomycin can NO LONGER BIND
Resistances of S. aureus
1) PENICILLINASE - Resistant to penicillin
MRSA - methicillin resistant S. aureus (methicillin = “penicillinase-resistant” anti-staphylococcal beta-lacftams
2) VISA / VRSA - vancomycin intermediate/resistant S. aureus
beta-lactamase resistant penicillins (beta-lactam)
Nafcillin
Macrolide used to treat Chlamydia AND also gonorrhea or neonatal conjunctivitis (N. gonorrheae infections)
We have to assume Chlamydia co-infection whenever patient has gonorrhea
Azithromycin
Erythromycin
Clarithromycin
Telithromycin
N. gonorrheae is resistant to which antibiotics
Penicillin
Tetracycline
Quinolones
Reason: 20-30% of new gonorrhea cases are PPNG (penillinase-producing)/ TRNG (tetracycline resistant)/ QRNG (quinolone resistant)
2 IV aminoglycoside antibiotics used to treat SERIOUS infections
Gentamicin
Tobramycin
2nd line agent used to treat tuberculosis = __
What drug is this antibiotic combined with __
Streptomycin
Combined with INH or Rifampin - To prevent emergence of drug resistance